Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric suit aims to ease spasticity and boost balance in kids with cerebral palsy

NCT ID NCT05885139

Symptom relief Sponsor: Exoneural Network AB Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether a wearable suit called EXOPULSE Mollii, which sends gentle electrical pulses to muscles, can help children with cerebral palsy. The study focuses on kids aged 5 to 12 who have spasticity and some walking ability. Researchers will measure changes in balance, spasticity, and pain to see if the suit offers a non-invasive way to improve daily life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
EXOPULSE Mollii Suit, a wearable garment with embedded electrodes that delivers low-intensity electrical pulses to muscles
What this could lead to
If effective, this non-invasive suit could offer a new way to improve balance, mobility, and quality of life while reducing spasticity and pain in children with cerebral palsy.
What could go wrong
This is a small early-stage trial, so results may not apply broadly. The suit's benefits are uncertain, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Apr 2023

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients will be included if they * are between 5 and 12 years of age. * have a clinical diagnosis of unilateraal or bilateral spastic CP by birth \[15\]. * have a PBS score between a minimum of 15 and a maxmimum of 44 points. * are able to walk freely, with slight limitation or using ancillary equipment's (GMFCS score ≤3) \[49\]. * are German speakers, able to understand verbal instructions. * have spasticity with a score of at least 1+ on the MAS Exclusion Criteria: Patients will not be included if they * are included in another research protocol during the study period. * are unable to undergo clinical procedures for the study purposes due to geographical or social reasons. * have a cardiac stimulator, a ventriculoperitoneal shunt, intrathecal baclofen pump. * have a change in their pharmacological therapy over the last three months or are planning to do so during the study. * suffer from other somatic or neuropsychiatric diagnoses (e.g., arrhythmias, uncontrolled epilepsy, diseases causing osteoarticular and muscular pain). * have a body mass index above 35 kg/m2, * have contraindications to wearing Exopulse Mollii Suit, receive a medical device other than Exopulse Mollii during the study period. * have received botulinum toxin (botox) therapy in the last 3 months before the start of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy hemiplegia Muscle Spasticity myopathy quadriplegia somatoform disorder spastic cerebral palsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance Cerebral palsy Diplegia Hemiplegia MUSCLE Pain syndrome Spasticity Tetraplegia

Contacts and locations

Locations

  • Medizinische Hochschule Hannover (MHH)

    Hanover, Germany

  • Pohlig GmbH

    Traunstein, Bavaria, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.